PEOPLE - AtriCure makes appointment
This article was originally published in Clinica
AtriCure, a manufacturer of cardiac ablation systems, based in West Chester, Ohio, has appointed veteran life sciences executive Mark Collar to its board of directors. Mr Collar is chairman of Ohio's $1.6bn fund for high-tech research, innovation and company formation (the Third Frontier Advisory Board) and vice-chairman and member of the executive committee of BioOhio, which promotes the growth of local life-science companies. He joins from Procter & Gamble, where he was president of the global pharmaceuticals division.
You may also be interested in...
Stephen Hahn’s low visibility period as the newly installed FDA commissioner comes to an abrupt end. Trump offers generous praise amid COVID-19 response – but how quickly might that change to blame?
The latest drug development news and highlights from the Pink Sheet US FDA Performance Tracker.
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.